ClinicalTrials.gg
Sign In

Intraabdominal Infections clinical trials

The registry lists 129 studies for Intraabdominal Infections across more than 10 countries. 15 are recruiting or about to start. 70 of them are mainly about Intraabdominal Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-02. Counting its 2 narrower conditions too, such as Appendicitis: 684 studies, 102 open.

Get an email when these change. Save the Intraabdominal Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
87
Status unknown
16
Recruiting
10
Not yet recruiting
5
Withdrawn
4
Terminated
4

Phase

Phase 3
26
Phase 2
20
Phase 4
13
Phase 1
6

Where

United States
29
China
22
France
20
Greece
14
Russian Federation
14
Italy
13

Who runs them

Pfizer (14) · Merck Sharp & Dohme LLC (9) · Wyeth is now a wholly owned subsidiary of Pfizer (5) · Central Hospital, Nancy, France (5) · Tetraphase Pharmaceuticals, Inc. (3) · Inflammatix (3) · World Society of Emergency Surgery (2) · Tianjin Medical University Cancer Institute and Hospital (2)

What is being tested here

Drugs under test in Intraabdominal Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pralurbactam111
Lidocaine101
Metronidazole034
Moxifloxacin034
Tigecycline003
Doripenem002
Sulopenem012
Ceftriaxone012
Allogeneic Ex-vivo-treated Peripheral Blood Mononuclear Cells001
Micafungin001

Drug classes tested here Beta-lactamase inhibitors 1 open

Coming up

1phase 3 study under way
4studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4, phase 3 first

Who these studies take

Of the 10 Intraabdominal Infections studies recruiting now, 6 (60%) set no upper age limit and 3 (30%) stop at 75 or younger. 2 (20%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (20%) take healthy volunteers.

Recruiting studies that take each age, of 10
AgeWomenMen
102 (20%)2 (20%)
189 (90%)9 (90%)
309 (90%)9 (90%)
409 (90%)9 (90%)
508 (80%)8 (80%)
658 (80%)8 (80%)
757 (70%)7 (70%)
857 (70%)7 (70%)

Across all 129 studies, recruiting or not: 20% stop at 75 or younger and 14% at 65; 15% take children; 0% are for women only and 0% for men only; 6% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Intraabdominal Infections studies take

Of 24 observational studies under Intraabdominal Infections, half reached primary completion within 12 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Observational12 mo10–35 · 24 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 129. Browse all 129 → or search them.